104 related articles for article (PubMed ID: 8438495)
1. Chemically engineered bispecific antibody directed at the p55 and p75 chains of the human interleukin 2 receptor: specific high-affinity cross-linking of p55/p75 complexes and high blocking effect on IL2-induced T cell proliferation.
François C; Boeffard F; Jacques Y
Transplant Proc; 1993 Feb; 25(1 Pt 1):815-6. PubMed ID: 8438495
[No Abstract] [Full Text] [Related]
2. Synergistic action of monoclonal antibodies directed at p55 and p75 chains of the human IL-2-receptor.
Audrain M; Boeffard F; Soulillou JP; Jacques Y
J Immunol; 1991 Feb; 146(3):884-92. PubMed ID: 1988501
[TBL] [Abstract][Full Text] [Related]
3. Concerted action of monoclonal antibodies directed at the P55 and P75 chains of the human interleukin-2 receptor.
Jacques Y; Audrain M; Boeffard F; Soulillou JP
Transplant Proc; 1991 Feb; 23(1 Pt 2):1068-9. PubMed ID: 1989151
[No Abstract] [Full Text] [Related]
4. Activation of leukemic large granular lymphocytes by interleukin-2 via the p75 interleukin-2 receptor.
Yoon HJ; Sugamura K; Loughran TP
Leukemia; 1990 Dec; 4(12):848-50. PubMed ID: 2147047
[TBL] [Abstract][Full Text] [Related]
5. Construction of a bispecific antibody reacting with the alpha- and beta-chains of the human IL-2 receptor. High affinity cross-linking and high anti-proliferative efficiency.
Francois C; Boeffard F; Kaluza B; Weidle UH; Jacques Y
J Immunol; 1993 May; 150(10):4610-9. PubMed ID: 8482850
[TBL] [Abstract][Full Text] [Related]
6. Direct identification of the murine IL-2 receptor p55-p75 heterodimer in the absence of IL-2.
Saragovi H; Malek TR
J Immunol; 1988 Jul; 141(2):476-82. PubMed ID: 3133409
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies identify three epitope clusters on the mouse p55 subunit of the interleukin 2 receptor: relationship to the interleukin 2-binding site.
Moreau JL; Nabholz M; Diamantstein T; Malek T; Shevach E; Thèze J
Eur J Immunol; 1987 Jul; 17(7):929-35. PubMed ID: 2440696
[TBL] [Abstract][Full Text] [Related]
8. Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.
Li J; Davis J; Bracht M; Carton J; Armstrong J; Gao W; Scallon B; Fung R; Emmell E; Zimmerman M; Griswold DE; Li L
Int Immunopharmacol; 2006 Jun; 6(6):880-91. PubMed ID: 16644473
[TBL] [Abstract][Full Text] [Related]
9. A newly established anti-interleukin-2 receptor beta chain (P75) monoclonal antibody inhibits the induction of allo-specific cytotoxic lymphocytes in combination with anti-interleukin-2 receptor alpha chain (P55) monoclonal antibody.
Niguma T; Sakagami K; Orita K
Transplant Proc; 1991 Feb; 23(1 Pt 1):290-4. PubMed ID: 1990535
[No Abstract] [Full Text] [Related]
10. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
11. Human IgG2 variants of chimeric anti-CD3 are nonmitogenic to T cells.
Cole MS; Anasetti C; Tso JY
J Immunol; 1997 Oct; 159(7):3613-21. PubMed ID: 9317161
[TBL] [Abstract][Full Text] [Related]
12. The murine anti-human common gamma chain monoclonal antibody CP.B8 blocks the second step in the formation of the intermediate affinity IL-2 receptor.
Baker DP; Whitty A; Zafari MR; Olson DL; Hession CA; Miatkowski K; Avedissian LS; Foley SF; McKay ML; Benjamin CD; Burkly LC
Biochemistry; 1998 Oct; 37(41):14337-49. PubMed ID: 9772159
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin G-mediated inhibition of T-cell proliferation reflects an endogenous mechanism by which IgG modulates T-cell activation.
MacMillan HF; Lee T; Issekutz AC
Clin Immunol; 2009 Aug; 132(2):222-33. PubMed ID: 19447680
[TBL] [Abstract][Full Text] [Related]
14. Biological activities on T lymphocytes of a baculovirus-expressed chimeric recombinant IgG1 antibody with specificity for the CDR3-like loop on the D1 domain of the CD4 molecule.
Troadec S; Bès C; Chentouf M; Nguyen B; Briant L; Jacquet C; Chebli K; Pugnière M; Roquet F; Cerutti M; Chardès T
Clin Immunol; 2006 Apr; 119(1):38-50. PubMed ID: 16426893
[TBL] [Abstract][Full Text] [Related]
15. Gangliosides inhibit T-lymphocyte proliferation by preventing the interaction of interleukin-2 with its cell surface receptors.
Chu JW; Sharom FJ
Immunology; 1993 May; 79(1):10-7. PubMed ID: 8509130
[TBL] [Abstract][Full Text] [Related]
16. Activation of human effector cells by a tumor reactive recombinant anti-ganglioside GD2 interleukin-2 fusion protein (ch14.18-IL2).
Hank JA; Surfus JE; Gan J; Jaeger P; Gillies SD; Reisfeld RA; Sondel PM
Clin Cancer Res; 1996 Dec; 2(12):1951-9. PubMed ID: 9816154
[TBL] [Abstract][Full Text] [Related]
17. T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors.
Alexander JP; Kudoh S; Melsop KA; Hamilton TA; Edinger MG; Tubbs RR; Sica D; Tuason L; Klein E; Bukowski RM
Cancer Res; 1993 Mar; 53(6):1380-7. PubMed ID: 8443817
[TBL] [Abstract][Full Text] [Related]
18. IL-2-induced IL-9 production by allergen-specific human helper T-cell clones.
Kajiyama Y; Umezu-Goto M; Kobayashi N; Takahashi K; Fukuchi Y; Mori A
Int Arch Allergy Immunol; 2007; 143 Suppl 1():71-5. PubMed ID: 17541281
[TBL] [Abstract][Full Text] [Related]
19. Switching on of the proliferation or apoptosis of activated human T lymphocytes by IFN-gamma is correlated with the differential expression of the alpha- and beta-chains of its receptor.
Novelli F; Bernabei P; Ozmen L; Rigamonti L; Allione A; Pestka S; Garotta G; Forni G
J Immunol; 1996 Sep; 157(5):1935-43. PubMed ID: 8757312
[TBL] [Abstract][Full Text] [Related]
20. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
